Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029

Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029

The value of the human organoids market will increase from an estimated USD 1.19 billion in 2024 to USD 2.33 billion in 2029, at a CAGR of 14.4% through the forecast period.

Advancement in funding for research in human organoids directly promotes the growth of the market for organoids with significant improvement in research capabilities and increases the scope of applications. Financial support brings scientists to explore organoids in various fields, such as cancer, neurodegenerative diseases, and drug development, which attracts pharmaceutical and biotech companies. A more commercialized version of the organoid technologies along with a clear regulatory framework will even further ease access to the market. This, in turn, is fuelling the growth of the global human organoids market. Although the growing interest in human organoids provides a major market potential, there is a dearth of skilled labor. With such increasing demand in innovative organoid technology, the shortage of qualified personnel who are able to develop and use such complex models has become a challenge to the continued research and commercialization effort.

“Developmental biology segment is expected to have the fastest growth rate in the human organoids market, by application, during the forecast period.”

The human organoids market is segmented into developmental biology, drug toxicity & efficacy testing, disease pathology, personalized medicine, regenerative medicine, and other applications, based on application. Human organoids represent an essentially much more ethically compliant and efficient alternative to studying human-specific developmental biology and the processes leading to disease. It is therefore increasingly being applied, especially in academic and research centers specializing in developmental biology.

“Pharmaceutical & biotechnology companies segment accounted for the highest growth rate in the human organoids market, by end user, during the forecast period.”

Based on end user, the human organoids market is bifurcated into into pharmaceutical & biotechnology companies, contract research organizations, academic & research institutes, and other end users. The pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR in the market of human organoids mainly due to their intense research and development activities, where they use organoids in drug discovery, disease modeling, and personalized medicine. These companies employ organoids in developing new drugs and testing them for the efficacy and toxicity of the drug, besides gaining insights into the complexities of a diseaseat a cellular level.

“Asia Pacific: The fastest-growing region in human organoids market.”

The worldwide market for human organoids is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. Notably, the Asia-Pacific region marks the highest CAGR in the human organoids market, due to increasing investments into healthcare infrastructure and research that advance the capabilities of medical facilities. In addition to this, the number of rapidly aging patients strongly demands effective treatments for diseases related to age. Consequently, human organoids act as great models for the study of such conditions. The growing medical tourism activities in the APAC region also happen to be of great influence for the market, given the rapid increase of patients seeking advanced treatments and high-class healthcare services. These factors, collectively, have put the APAC region on a growth trajectory for human organoids markets.

The break-up of the profile of primary participants in the human organoids market:

By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%

By Designation: C-level - 27%, D-level - 18%, and Others - 55%

By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%

The key players in this market are Thermo Fisher Scientific Inc. (US), Corning Incorporated (US), Merck KGaA (Germany), BioIVT (US), HUB Organoids BV (Netherlands), BICO (Sweden), BeCytes Biotechnologies SL (Spain), InSphero (Switzerland), GBA Group (Germany), Kirkstall Ltd. (UK), MIMETAS BV (Netherlands), Neuromics (US), PRIMACYT Cell Culture Technology GmbH (Germany), STEMCELL Technologies (Canada), ACROBiosystems (China), Biopredic International (France), CN Bio Innovations Ltd. (UK), CYPRIO (France), Emulate, Inc. (US), Kerafast, Inc. (US), Pandorum Technologies Pvt. Ltd (India), CYFUSE BIOMEDICAL K.K. (Japan), NeyroblastGX LLC (US), 3Dnamics Inc. (US), and DefiniGEN Limited (UK).

Research Coverage:

This research report categorizes the human organoids market by product (Liver models, kidney models, pancreatic models, colorectal models, heart models, lung models, other products), by source (adult stem cells, induced pluripotent stem cells, embryonic stem cells, other sources), by type (ready-to-use products, customizable products), by culture method (air-liquid interface culture, suspension culture, matrigel matrix culture, 3d bioprinting culture, and other culture methods), by disease area (oncology, liver diseases, gastrointestinal diseases, cardiovascular diseases, infectious diseases, neurological disorders, and other disease areas), by apllication (developmental biology, drug toxicity & efficacy testing, disease pathology, personalized medicine, regenerative medicine, and other applications), by end user (pharmaceutical & biotechnology companies, contract research organizations, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the human organoids market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the human organoids market. Competitive analysis of upcoming startups in the human organoids market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall human organoids market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Growing focus on developing alternatives to animal testing, rising R&D funding and venture capital investments, increasing research on organoids, increasing prevalence of non-alcoholic fatty liver disease , and need for early detection of drug toxicity to minimize financial losses caused by late-stage drug failure), opportunities (Increasing focus on drug discovery activities, rising demand for organ transplantation, and growth opportunities in emerging economies), restraints (Issues related to incorporating organoids into existing workflows), and challenges (Dearth of skilled professionals) influencing the growth of the human organoids market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the human organoids market.

Market Development: Comprehensive information about lucrative markets – the report analyses the human organoids market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the human organoids market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Thermo Fisher Scientific Inc. (US), Corning Incorporated (US), Merck KGaA (Germany), BioIVT (US), and HUB Organoids BV (Netherlands).

Tables List

Table 1 Investments And Funds For Human Organoid Research

Table 2 Research Projects And Activities

Table 3 Average Selling Price Of Human Organoid Products, By Type,

2022–2024

Table 4 Average Selling Price Of Human Organoid Products, By Region,

2022–2024

Table 5 Human Organoids Market: List Of Major Patents, 2022–2023

Table 6 Import Data For Hs Code 3002, Which Includes Cell Cultures,

Whether Or Not Modified, 2019–2023 (Usd Million)

Table 7 Export Data For Hs Code 3002, Which Includes Cell Cultures,

Whether Or Not Modified, By Country, 2019–2023 (Usd Million)

Table 8 Human Organoids Market: Role In Ecosystem

Table 9 Human Organoids Market: Porter’s Five Forces

Table 10 Influence Of Stakeholders On Buying Process Of Human Organoids (%)

Table 11 Key Buying Criteria For Human Organoids, By Type

Table 12 North America: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 13 Europe: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 14 Asia Pacific: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 15 Latin America: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 16 Rest Of The World: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 17 Human Organoids Market: Detailed List Of Key Conferences

And Events, January 2024–december 2025

Table 18 Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 19 Liver Models: Key Products Offered, By Company

Table 20 Liver And Intrahepatic Bile Duct Cancer Incidence, 2022

Table 21 Human Organoids Market For Liver Models, By Region,

2022–2029 (Usd Million)

Table 22 North America: Human Organoids Market For Liver Models, By Country, 2022–2029 (Usd Million)

Table 23 Europe: Human Organoids Market For Liver Models, By Country,

2022–2029 (Usd Million)

Table 24 Asia Pacific: Human Organoids Market For Liver Models, By Country, 2022–2029 (Usd Million)

Table 25 Latin America: Human Organoids Market For Liver Models, By Country, 2022–2029 (Usd Million)

Table 26 Human Organoids Market For Liver Models, By Type,

2022–2029 (Usd Million)

Table 27 2d Liver Models Market, By Region, 2022–2029 (Usd Million)

Table 28 2d Liver Models Market, By Type, 2022–2029 (Usd Million)

Table 29 Fresh Hepatocytes: Key Products Offered, By Company

Table 30 Fresh Hepatocytes Market, By Region, 2022–2029 (Usd Million)

Table 31 Cryopreserved Hepatocytes: Key Products Offered, By Company

Table 32 Cryopreserved Hepatocytes Market, By Region,

2022–2029 (Usd Million)

Table 33 Other 2d Liver Models Market, By Region, 2022–2029 (Usd Million)

Table 34 3d Liver Models Market, By Region, 2022–2029 (Usd Million)

Table 35 3d Liver Models Market, By Type, 2022–2029 (Usd Million)

Table 36 Liver Organoids Market, By Region, 2022–2029 (Usd Million)

Table 37 3d Bioprinted Liver Models Market, By Region, 2022–2029 (Usd Million)

Table 38 Liver Spheroids Market, By Region, 2022–2029 (Usd Million)

Table 39 Liver-on-a Chip Market, By Region, 2022–2029 (Usd Million)

Table 40 Other 3d Liver Models Market, By Region, 2022–2029 (Usd Million)

Table 41 Kidney Models: Key Products Offered, By Company

Table 42 Kidney Cancer Incidence, 2022

Table 43 Human Organoids Market For Kidney Models, By Region,

2022–2029 (Usd Million)

Table 44 North America: Human Organoids Market For Kidney Models,

By Country, 2022–2029 (Usd Million)

Table 45 Europe: Human Organoids Market For Kidney Models, By Country, 2022–2029 (Usd Million)

Table 46 Asia Pacific: Human Organoids Market For Kidney Models, By Country, 2022–2029 (Usd Million)

Table 47 Latin America: Human Organoids Market For Kidney Models,

By Country, 2022–2029 (Usd Million)

Table 48 Human Organoids Market For Kidney Models, By Type,

2022–2029 (Usd Million)

Table 49 2d Kidney Models Market, By Region, 2022–2029 (Usd Million)

Table 50 2d Kidney Models Market, By Type, 2022–2029 (Usd Million)

Table 51 Fresh Kidney Cells Market, By Region, 2022–2029 (Usd Million)

Table 52 Cryopreserved Kidney Cells Market, By Region,

2022–2029 (Usd Million)

Table 53 Other 2d Kidney Models Market, By Region, 2022–2029 (Usd Million)

Table 54 3d Kidney Models Market, By Region, 2022–2029 (Usd Million)

Table 55 3d Kidney Models Market, By Type, 2022–2029 (Usd Million)

Table 56 Kidney Organoids Market, By Region, 2022–2029 (Usd Million)

Table 57 3d Bioprinted Kidney Models Market, By Region,

2022–2029 (Usd Million)

Table 58 Kidney Spheroids Market, By Region, 2022–2029 (Usd Million)

Table 59 Other 3d Kidney Models Market, By Region, 2022–2029 (Usd Million)

Table 60 Pancreatic Models: Key Products Offered, By Company

Table 61 Pancreatic Cancer Incidence, 2022

Table 62 Human Organoids Market For Pancreatic Models, By Region,

2022–2029 (Usd Million)

Table 63 North America: Human Organoids Market For Pancreatic Models,

By Country, 2022–2029 (Usd Million)

Table 64 Europe: Human Organoids Market For Pancreatic Models, By Country, 2022–2029 (Usd Million)

Table 65 Asia Pacific: Human Organoids Market For Pancreatic Models,

By Country, 2022–2029 (Usd Million)

Table 66 Latin America: Human Organoids Market For Pancreatic Models,

By Country, 2022–2029 (Usd Million)

Table 67 Human Organoids Market For Pancreatic Models, By Type,

2022–2029 (Usd Million)

Table 68 2d Pancreatic Models Market, By Region, 2022–2029 (Usd Million)

Table 69 2d Pancreatic Models Market, By Type, 2022–2029 (Usd Million)

Table 70 Fresh Pancreatic Cells Market, By Region, 2022–2029 (Usd Million)

Table 71 Cryopreserved Pancreatic Cells Market, By Region,

2022–2029 (Usd Million)

Table 72 Other 2d Pancreatic Models Market, By Region,

2022–2029 (Usd Million)

Table 73 3d Pancreatic Models Market, By Region, 2022–2029 (Usd Million)

Table 74 3d Pancreatic Models Market, By Type, 2022–2029 (Usd Million)

Table 75 Pancreatic Organoids Market, By Region, 2022–2029 (Usd Million)

Table 76 3d Bioprinted Pancreatic Models Market, By Region,

2022–2029 (Usd Million)

Table 77 Pancreatic Spheroids Market, By Region, 2022–2029 (Usd Million)

Table 78 Other 3d Pancreatic Models Market, By Region,

2022–2029 (Usd Million)

Table 79 Colorectal Models: Key Products Offered, By Company

Table 80 Colorectal Cancer Incidence, 2022

Table 81 Human Organoids Market For Colorectal Models, By Region,

2022–2029 (Usd Million)

Table 82 North America: Human Organoids Market For Colorectal Models,

By Country, 2022–2029 (Usd Million)

Table 83 Europe: Human Organoids Market For Colorectal Models, By Country, 2022–2029 (Usd Million)

Table 84 Asia Pacific: Human Organoids Market For Colorectal Models,

By Country, 2022–2029 (Usd Million)

Table 85 Latin America: Human Organoids Market For Colorectal Models,

By Country, 2022–2029 (Usd Million)

Table 86 Human Organoids Market For Colorectal Models, By Type,

2022–2029 (Usd Million)

Table 87 2d Colorectal Models Market, By Region, 2022–2029 (Usd Million)

Table 88 2d Colorectal Models Market, By Type, 2022–2029 (Usd Million)

Table 89 Fresh Colorectal Cells Market, By Region, 2022–2029 (Usd Million)

Table 90 Cryopreserved Colorectal Cells Market, By Region,

2022–2029 (Usd Million)

Table 91 Other 2d Colorectal Models Market, By Region,

2022–2029 (Usd Million)

Table 92 3d Colorectal Models Market, By Region, 2022–2029 (Usd Million)

Table 93 3d Colorectal Models Market, By Type, 2022–2029 (Usd Million)

Table 94 Colorectal Organoids Market, By Region, 2022–2029 (Usd Million)

Table 95 3d Bioprinted Colorectal Models Market, By Region,

2022–2029 (Usd Million)

Table 96 Colorectal Spheroids Market, By Region, 2022–2029 (Usd Million)

Table 97 Other 3d Colorectal Models Market, By Region,

2022–2029 (Usd Million)

Table 98 Human Organoids Market For Heart Models, By Region,

2022–2029 (Usd Million)

Table 99 North America: Human Organoids Market For Heart Models,

By Country, 2022–2029 (Usd Million)

Table 100 Europe: Human Organoids Market For Heart Models, By Country,

2022–2029 (Usd Million)

Table 101 Asia Pacific: Human Organoids Market For Heart Models, By Country, 2022–2029 (Usd Million)

Table 102 Latin America: Human Organoids Market For Heart Models, By Country, 2022–2029 (Usd Million)

Table 103 Human Organoids Market For Heart Models, By Type,

2022–2029 (Usd Million)

Table 104 2d Heart Models Market, By Region, 2022–2029 (Usd Million)

Table 105 2d Heart Models Market, By Type, 2022–2029 (Usd Million)

Table 106 Fresh Heart Cells Market, By Region, 2022–2029 (Usd Million)

Table 107 Cryopreserved Heart Cells Market, By Region, 2022–2029 (Usd Million)

Table 108 Other 2d Heart Models Market, By Region, 2022–2029 (Usd Million)

Table 109 3d Heart Models Market, By Region, 2022–2029 (Usd Million)

Table 110 3d Heart Models Market, By Type, 2022–2029 (Usd Million)

Table 111 Heart Organoids Market, By Region, 2022–2029 (Usd Million)

Table 112 3d Bioprinted Heart Models Market, By Region,

2022–2029 (Usd Million)

Table 113 Heart Spheroids Market, By Region, 2022–2029 (Usd Million)

Table 114 Other 3d Heart Models Market, By Region, 2022–2029 (Usd Million)

Table 115 Lung Models: Key Products Offered, By Company

Table 116 Lung Cancer Incidence,2022

Table 117 Human Organoids Market For Lung Models, By Region,

2022–2029 (Usd Million)

Table 118 North America: Human Organoids Market For Lung Models, By Country, 2022–2029 (Usd Million)

Table 119 Europe: Human Organoids Market For Lung Models, By Country,

2022–2029 (Usd Million)

Table 120 Asia Pacific: Human Organoids Market For Lung Models, By Country, 2022–2029 (Usd Million)

Table 121 Latin America: Human Organoids Market For Lung Models, By Country, 2022–2029 (Usd Million)

Table 122 Human Organoids Market For Lung Models, By Type,

2022–2029 (Usd Million)

Table 123 2d Lung Models Market, By Region, 2022–2029 (Usd Million)

Table 124 2d Lung Models Market, By Type, 2022–2029 (Usd Million)

Table 125 Fresh Lung Cells Market, By Region, 2022–2029 (Usd Million)

Table 126 Cryopreserved Lung Cells Market, By Region, 2022–2029 (Usd Million)

Table 127 Other 2d Lung Models Market, By Region, 2022–2029 (Usd Million)

Table 128 3d Lung Models Market, By Region, 2022–2029 (Usd Million)

Table 129 3d Lung Models Market, By Type, 2022–2029 (Usd Million)

Table 130 Lung Organoids Market, By Region, 2022–2029 (Usd Million)

Table 131 3d Bioprinted Lung Models Market, By Region, 2022–2029 (Usd Million)

Table 132 Lung Spheroids Market, By Region, 2022–2029 (Usd Million)

Table 133 Other 3d Lung Models Market, By Region, 2022–2029 (Usd Million)

Table 134 Other Products: Key Products Offered, By Company

Table 135 Brain, Central Nervous System, And Breast Cancer Incidence, 2022

Table 136 Other Human Organoid Products Market, By Region,

2022–2029 (Usd Million)

Table 137 North America: Other Human Organoid Products Market, By Country, 2022–2029 (Usd Million)

Table 138 Europe: Other Human Organoid Products Market, By Country,

2022–2029 (Usd Million)

Table 139 Asia Pacific: Other Human Organoid Products Market, By Country, 2022–2029 (Usd Million)

Table 140 Latin America: Other Human Organoid Products Market, By Country, 2022–2029 (Usd Million)

Table 141 Other Human Organoid Products Market, By Type,

2022–2029 (Usd Million)

Table 142 2d Models (Other Products) Market, By Region,

2022–2029 (Usd Million)

Table 143 2d Models (Other Products) Market, By Type,

2022–2029 (Usd Million)

Table 144 Fresh Cells (Other Products) Market, By Region,

2022–2029 (Usd Million)

Table 145 Cryopreserved Cells (Other Products) Market, By Region,

2022–2029 (Usd Million)

Table 146 Other 2d Models (Other Products) Market, By Region,

2022–2029 (Usd Million)

Table 147 3d Models (Other Products) Market, By Region,

2022–2029 (Usd Million)

Table 148 3d Models (Other Products) Market, By Type, 2022–2029 (Usd Million)

Table 149 Organoids (Other Products) Market, By Region,

2022–2029 (Usd Million)

Table 150 3d Bioprinted Models (Other Products) Market, By Region,

2022–2029 (Usd Million)

Table 151 Spheroids (Other Products) Market, By Region, 2022–2029 (Usd Million)

Table 152 Other 3d Models (Other Products) Market, By Region,

2022–2029 (Usd Million)

Table 153 Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 154 Adult Stem Cells Market, By Region, 2022–2029 (Usd Million)

Table 155 North America: Adult Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 156 Europe: Adult Stem Cells Market, By Country, 2022–2029 (Usd Million)

Table 157 Asia Pacific: Adult Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 158 Latin America: Adult Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 159 Induced Pluripotent Stem Cells: Key Products Offered, By Company

Table 160 Induced Pluripotent Stem Cells Market, By Region,

2022–2029 (Usd Million)

Table 161 North America: Induced Pluripotent Stem Cells Market, By Country, 2022–2029 (Usd Million)

Table 162 Europe: Induced Pluripotent Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 163 Asia Pacific: Induced Pluripotent Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 164 Latin America: Induced Pluripotent Stem Cells Market, By Country, 2022–2029 (Usd Million)

Table 165 Embryonic Stem Cells Market, By Region, 2022–2029 (Usd Million)

Table 166 North America: Embryonic Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 167 Europe: Embryonic Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 168 Asia Pacific: Embryonic Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 169 Latin America: Embryonic Stem Cells Market, By Country,

2022–2029 (Usd Million)

Table 170 Other Sources: Key Products Offered, By Company

Table 171 Other Human Organoid Sources Market, By Region,

2022–2029 (Usd Million)

Table 172 North America: Other Human Organoid Sources Market, By Country, 2022–2029 (Usd Million)

Table 173 Europe: Other Human Organoid Sources Market, By Country,

2022–2029 (Usd Million)

Table 174 Asia Pacific: Other Human Organoid Sources Market, By Country,

2022–2029 (Usd Million)

Table 175 Latin America: Other Human Organoid Sources Market, By Country, 2022–2029 (Usd Million)

Table 176 Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 177 Ready-to-use Products Market: Key Products, By Company

Table 178 Ready-to-use Human Organoid Products Market, By Region,

2022–2029 (Usd Million)

Table 179 North America: Ready-to-use Human Organoid Products Market,

By Country, 2022–2029 (Usd Million)

Table 180 Europe: Ready-to-use Human Organoid Products Market, By Country, 2022–2029 (Usd Million)

Table 181 Asia Pacific: Ready-to-use Human Organoid Products Market,

By Country, 2022–2029 (Usd Million)

Table 182 Latin America: Ready-to-use Human Organoid Products Market,

By Country, 2022–2029 (Usd Million)

Table 183 Customizable Human Organoid Products Market, By Region,

2022–2029 (Usd Million)

Table 184 North America: Customizable Human Organoid Products Market,

By Country, 2022–2029 (Usd Million)

Table 185 Europe: Customizable Human Organoid Products Market, By Country, 2022–2029 (Usd Million)

Table 186 Asia Pacific: Customizable Human Organoid Products Market,

By Country, 2022–2029 (Usd Million)

Table 187 Latin America: Customizable Human Organoid Products Market,

By Country, 2022–2029 (Usd Million)

Table 188 Human Organoids Market, By Culture Method, 2022–2029 (Usd Million)

Table 189 Human Organoids Market For Matrigel Matrix Culture, By Region, 2022–2029 (Usd Million)

Table 190 North America: Human Organoids Market For Matrigel Matrix Culture, By Country, 2022–2029 (Usd Million)

Table 191 Europe: Human Organoids Market For Matrigel Matrix Culture,

By Country, 2022–2029 (Usd Million)

Table 192 Asia Pacific: Human Organoids Market For Matrigel Matrix Culture,

By Country, 2022–2029 (Usd Million)

Table 193 Latin America: Human Organoids Market For Matrigel Matrix Culture, By Country, 2022–2029 (Usd Million)

Table 194 Human Organoids Market For Air-liquid Interface Culture, By Region, 2022–2029 (Usd Million)

Table 195 North America: Human Organoids Market For Air-liquid Interface Culture, By Country, 2022–2029 (Usd Million)

Table 196 Europe: Human Organoids Market For Air-liquid Interface Culture,

By Country, 2022–2029 (Usd Million)

Table 197 Asia Pacific: Human Organoids Market For Air-liquid Interface Culture, By Country, 2022–2029 (Usd Million)

Table 198 Latin America: Human Organoids Market For Air-liquid Interface Culture, By Country, 2022–2029 (Usd Million)

Table 199 Human Organoids Market For Suspension Culture, By Region,

2022–2029 (Usd Million)

Table 200 North America: Human Organoids Market For Suspension Culture,

By Country, 2022–2029 (Usd Million)

Table 201 Europe: Human Organoids Market For Suspension Culture, By Country, 2022–2029 (Usd Million)

Table 202 Asia Pacific: Human Organoids Market For Suspension Culture,

By Country, 2022–2029 (Usd Million)

Table 203 Latin America: Human Organoids Market For Suspension Culture,

By Country, 2022–2029 (Usd Million)

Table 204 Human Organoids Market For 3d Bioprinting Culture, By Region,

2022–2029 (Usd Million)

Table 205 North America: Human Organoids Market For 3d Bioprinting Culture, By Country, 2022–2029 (Usd Million)

Table 206 Europe: Human Organoids Market For 3d Bioprinting Culture,

By Country, 2022–2029 (Usd Million)

Table 207 Asia Pacific: Human Organoids Market For 3d Bioprinting Culture,

By Country, 2022–2029 (Usd Million)

Table 208 Latin America: Human Organoids Market For 3d Bioprinting Culture,

By Country, 2022–2029 (Usd Million)

Table 209 Human Organoids Market For Other Culture Methods, By Region, 2022–2029 (Usd Million)

Table 210 North America: Human Organoids Market For Other Culture Methods, By Country, 2022–2029 (Usd Million)

Table 211 Europe: Human Organoids Market For Other Culture Methods,

By Country, 2022–2029 (Usd Million)

Table 212 Asia Pacific: Human Organoids Market For Other Culture Methods,

By Country, 2022–2029 (Usd Million)

Table 213 Latin America: Human Organoids Market For Other Culture Methods, By Country, 2022–2029 (Usd Million)

Table 214 Human Organoids Market, By Disease Area, 2022–2029 (Usd Million)

Table 215 Incidence Of Cancer Cases Worldwide, In 2022 Vs 2045, By Cancer Type

Table 216 Human Organoids Market For Oncology, By Region,

2022–2029 (Usd Million)

Table 217 North America: Human Organoids Market For Oncology, By Country, 2022–2029 (Usd Million)

Table 218 Europe: Human Organoids Market For Oncology, By Country,

2022–2029 (Usd Million)

Table 219 Asia Pacific: Human Organoids Market For Oncology, By Country,

2022–2029 (Usd Million)

Table 220 Latin America: Human Organoids Market For Oncology, By Country, 2022–2029 (Usd Million)

Table 221 Human Organoids Market For Liver Diseases, By Region,

2022–2029 (Usd Million)

Table 222 North America: Human Organoids Market For Liver Diseases,

By Country, 2022–2029 (Usd Million)

Table 223 Europe: Human Organoids Market For Liver Diseases, By Country, 2022–2029 (Usd Million)

Table 224 Asia Pacific: Human Organoids Market For Liver Diseases, By Country, 2022–2029 (Usd Million)

Table 225 Latin America: Human Organoids Market For Liver Diseases, By Country, 2022–2029 (Usd Million)

Table 226 Human Organoids Market For Gastrointestinal Diseases, By Region, 2022–2029 (Usd Million)

Table 227 North America: Human Organoids Market For Gastrointestinal Diseases, By Country, 2022–2029 (Usd Million)

Table 228 Europe: Human Organoids Market For Gastrointestinal Diseases,

By Country, 2022–2029 (Usd Million)

Table 229 Asia Pacific: Human Organoids Market For Gastrointestinal Diseases, By Country, 2022–2029 (Usd Million)

Table 230 Latin America: Human Organoids Market For Gastrointestinal Diseases, By Country, 2022–2029 (Usd Million)

Table 231 Human Organoids Market For Cardiovascular Diseases, By Region, 2022–2029 (Usd Million)

Table 232 North America: Human Organoids Market For Cardiovascular Diseases, By Country, 2022–2029 (Usd Million)

Table 233 Europe: Human Organoids Market For Cardiovascular Diseases,

By Country, 2022–2029 (Usd Million)

Table 234 Asia Pacific: Human Organoids Market For Cardiovascular Diseases,

By Country, 2022–2029 (Usd Million)

Table 235 Latin America: Human Organoids Market For Cardiovascular Diseases, By Country, 2022–2029 (Usd Million)

Table 236 Human Organoids Market For Infectious Diseases By Region,

2022–2029 (Usd Million)

Table 237 North America: Human Organoids Market For Infectious Diseases,

By Country, 2022–2029 (Usd Million)

Table 238 Europe: Human Organoids Market For Infectious Diseases, By Country, 2022–2029 (Usd Million)

Table 239 Asia Pacific: Human Organoids Market For Infectious Diseases,

By Country, 2022–2029 (Usd Million)

Table 240 Latin America: Human Organoids Market For Infectious Diseases,

By Country, 2022–2029 (Usd Million)

Table 241 Human Organoids Market For Neurological Disorders, By Region, 2022–2029 (Usd Million)

Table 242 North America: Human Organoids Market For Neurological Disorders, By Country, 2022–2029 (Usd Million)

Table 243 Europe: Human Organoids Market For Neurological Disorders,

By Country, 2022–2029 (Usd Million)

Table 244 Asia Pacific: Human Organoids Market For Neurological Disorders,

By Country, 2022–2029 (Usd Million)

Table 245 Latin America: Human Organoids Market For Neurological Disorders, By Country, 2022–2029 (Usd Million)

Table 246 Human Organoids Market For Other Disease Areas, By Region,

2022–2029 (Usd Million)

Table 247 North America: Human Organoids Market For Other Disease Areas,

By Country, 2022–2029 (Usd Million)

Table 248 Europe: Human Organoids Market For Other Disease Areas, By Country, 2022–2029 (Usd Million)

Table 249 Asia Pacific: Human Organoids Market For Other Disease Areas,

By Country, 2022–2029 (Usd Million)

Table 250 Latin America: Human Organoids Market For Other Disease Areas,

By Country, 2022–2029 (Usd Million)

Table 251 Human Organoids Market, By Application, 2022–2029 (Usd Million)

Table 252 Human Organoids Market For Developmental Biology, By Region,

2022–2029 (Usd Million)

Table 253 North America: Human Organoids Market For Developmental Biology, By Country, 2022–2029 (Usd Million)

Table 254 Europe: Human Organoids Market For Developmental Biology,

By Country, 2022–2029 (Usd Million)

Table 255 Asia Pacific: Human Organoids Market For Developmental Biology,

By Country, 2022–2029 (Usd Million)

Table 256 Latin America: Human Organoids Market For Developmental Biology,

By Country, 2022–2029 (Usd Million)

Table 257 Human Organoids Market For Drug Toxicity & Efficacy Testing, By Region, 2022–2029 (Usd Million)

Table 258 North America: Human Organoids Market For Drug Toxicity & Efficacy Testing, By Country, 2022–2029 (Usd Million)

Table 259 Europe: Human Organoids Market For Drug Toxicity & Efficacy Testing, By Country, 2022–2029 (Usd Million)

Table 260 Asia Pacific: Human Organoids Market For Drug Toxicity &

Efficacy Testing, By Country, 2022–2029 (Usd Million)

Table 261 Latin America: Human Organoids Market For Drug Toxicity &

Efficacy Testing, By Country, 2022–2029 (Usd Million)

Table 262 Human Organoids Market For Disease Pathology, By Region,

2022–2029 (Usd Million)

Table 263 North America: Human Organoids Market For Disease Pathology,

By Country, 2022–2029 (Usd Million)

Table 264 Europe: Human Organoids Market For Disease Pathology, By Country, 2022–2029 (Usd Million)

Table 265 Asia Pacific: Human Organoids Market For Disease Pathology,

By Country, 2022–2029 (Usd Million)

Table 266 Latin America: Human Organoids Market For Disease Pathology,

By Country, 2022–2029 (Usd Million)

Table 267 Human Organoids Market For Personalized Medicine, By Region,

2022–2029 (Usd Million)

Table 268 North America: Human Organoids Market For Personalized Medicine, By Country, 2022–2029 (Usd Million)

Table 269 Europe: Human Organoids Market For Personalized Medicine,

By Country, 2022–2029 (Usd Million)

Table 270 Asia Pacific: Human Organoids Market For Personalized Medicine,

By Country, 2022–2029 (Usd Million)

Table 271 Latin America: Human Organoids Market For Personalized Medicine,

By Country, 2022–2029 (Usd Million)

Table 272 Human Organoids Market For Regenerative Medicine, By Region,

2022–2029 (Usd Million)

Table 273 North America: Human Organoids Market For Regenerative Medicine, By Country, 2022–2029 (Usd Million)

Table 274 Europe: Human Organoids Market For Regenerative Medicine,

By Country, 2022–2029 (Usd Million)

Table 275 Asia Pacific: Human Organoids Market For Regenerative Medicine,

By Country, 2022–2029 (Usd Million)

Table 276 Latin America: Human Organoids Market For Regenerative Medicine,

By Country, 2022–2029 (Usd Million)

Table 277 Human Organoids Market For Other Applications, By Region,

2022–2029 (Usd Million)

Table 278 North America: Human Organoids Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 279 Europe: Human Organoids Market For Other Applications, By Country, 2022–2029 (Usd Million)

Table 280 Asia Pacific: Human Organoids Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 281 Latin America: Human Organoids Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 282 Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 283 Human Organoids Market For Pharmaceutical & Biotechnology Companies, By Region, 2022–2029 (Usd Million)

Table 284 North America: Human Organoids Market For Pharmaceutical & Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 285 Europe: Human Organoids Market For Pharmaceutical &

Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 286 Asia Pacific: Human Organoids Market For Pharmaceutical & Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 287 Latin America: Human Organoids Market For Pharmaceutical & Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 288 Human Organoids Market For Contract Research Organizations,

By Region, 2022–2029 (Usd Million)

Table 289 North America: Human Organoids Market For Contract Research Organizations, By Country, 2022–2029 (Usd Million)

Table 290 Europe: Human Organoids Market For Contract Research Organizations, By Country, 2022–2029 (Usd Million)

Table 291 Asia Pacific: Human Organoids Market For Contract Research Organizations, By Country, 2022–2029 (Usd Million)

Table 292 Latin America: Human Organoids Market For Contract Research Organizations, By Country, 2022–2029 (Usd Million)

Table 293 Human Organoids Market For Academic & Research Institutes,

By Region, 2022–2029 (Usd Million)

Table 294 North America: Human Organoids Market For Academic &

Research Institutes, By Country, 2022–2029 (Usd Million)

Table 295 Europe: Human Organoids Market For Academic & Research Institutes, By Country, 2022–2029 (Usd Million)

Table 296 Asia Pacific: Human Organoids Market For Academic & Research Institutes, By Country, 2022–2029 (Usd Million)

Table 297 Latin America: Human Organoids Market For Academic & Research Institutes, By Country, 2022–2029 (Usd Million)

Table 298 Human Organoids Market For Other End Users, By Region,

2022–2029 (Usd Million)

Table 299 North America: Human Organoids Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 300 Europe: Human Organoids Market For Other End Users, By Country, 2022–2029 (Usd Million)

Table 301 Asia Pacific: Human Organoids Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 302 Latin America: Human Organoids Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 303 Human Organoids Market, By Region, 2022–2029 (Usd Million)

Table 304 North America: Estimated Number Of New Cancer Cases

From 0 To 85+ Years Of Age, 2022–2045

Table 305 North America: Human Organoids Market, By Country,

2022–2029 (Usd Million)

Table 306 North America: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 307 North America: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 308 North America: Human Organoids Market, By Type,

2022–2029 (Usd Million)

Table 309 North America: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 310 North America: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 311 North America: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 312 North America: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 313 Us: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 314 Us: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 315 Us: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 316 Us: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 317 Us: Human Organoids Market, By Culture Method, 2022–2029 (Usd Million)

Table 318 Us: Human Organoids Market, By Disease Area, 2022–2029 (Usd Million)

Table 319 Us: Human Organoids Market, By Application, 2022–2029 (Usd Million)

Table 320 Us: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 321 Estimated Prevalence Of Diabetes In Canada, 2022 Vs. 2023

Table 322 Canada: Five Most-reported Causes Of Cancer-related Mortality, 2024

Table 323 Canada: Human Organo ids Market, By Product, 2022–2029 (Usd Million)

Table 324 Canada: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 325 Canada: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 326 Canada: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 327 Canada: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 328 Canada: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 329 Canada: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 330 Europe: Estimated Number Of New Cancer Cases

From 2022 To 2045, Both Sexes, Age [0-85+]

Table 331 Europe: Human Organoids Market, By Country, 2022–2029 (Usd Million)

Table 332 Europe: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 333 Europe: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 334 Europe: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 335 Europe: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 336 Europe: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 337 Europe: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 338 Europe: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 339 Germany: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 340 Germany: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 341 Germany: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 342 Germany: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 343 Germany: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 344 Germany: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 345 Germany: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 346 Germany: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 347 Uk: Incidence And Mortality Rate Of Heart And Circulatory

Diseases (Cvd), 2024

Table 348 Uk: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 349 Uk: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 350 Uk: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 351 Uk: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 352 Uk: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 353 Uk: Human Organoids Market, By Disease Area, 2022–2029 (Usd Million)

Table 354 Uk: Human Organoids Market, By Application, 2022–2029 (Usd Million)

Table 355 Uk: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 356 France: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 357 France: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 358 France: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 359 France: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 360 France: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 361 France: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 362 France: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 363 France: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 364 Italy: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 365 Italy: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 366 Italy: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 367 Italy: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 368 Italy: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 369 Italy: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 370 Italy: Human Organoids Market, By Application, 2022–2029 (Usd Million)

Table 371 Italy: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 372 Spain: Cancer Incidence, 2022 Vs 2023

Table 373 Spain: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 374 Spain: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 375 Spain: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 376 Spain: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 377 Spain: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 378 Spain: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 379 Spain: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 380 Rest Of Europe: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 381 Rest Of Europe: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 382 Rest Of Europe: Human Organoids Market, By Type,

2022–2029 (Usd Million)

Table 383 Rest Of Europe: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 384 Rest Of Europe: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 385 Rest Of Europe: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 386 Rest Of Europe: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 387 Asia Pacific: Estimated Number Of New Cancer Cases

From 2022 To 2045, Both Sexes, Age [0-85+]

Table 388 Asia Pacific: Human Organoids Market, By Country,

2022–2029 (Usd Million)

Table 389 Asia Pacific: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 390 Asia Pacific: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 391 Asia Pacific: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 392 Asia Pacific: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 393 Asia Pacific: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 394 Asia Pacific: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 395 Asia Pacific: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 396 China: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 397 China: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 398 China: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 399 China: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 400 China: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 401 China: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 402 China: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 403 China: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 404 Japan: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 405 Japan: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 406 Japan: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 407 Japan: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 408 Japan: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 409 Japan: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 410 Japan: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 411 Japan: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 412 India: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 413 India: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 414 India: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 415 India: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 416 India: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 417 India: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 418 India: Human Organoids Market, By Application, 2022–2029 (Usd Million)

Table 419 India: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 420 Australia: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 421 Australia: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 422 Australia: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 423 Australia: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 424 Australia: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 425 Australia: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 426 Australia: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 427 Australia: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 428 South Korea: Cancer Incidence, Mortality And Prevalence,

By Type, 2022

Table 429 South Korea: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 430 South Korea: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 431 South Korea: Human Organoids Market, By Type,

2022–2029 (Usd Million)

Table 432 South Korea: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 433 South Korea: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 434 South Korea: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 435 South Korea: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 436 Rest Of Asia Pacific: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 437 Rest Of Asia Pacific: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 438 Rest Of Asia Pacific: Human Organoids Market, By Type,

2022–2029 (Usd Million)

Table 439 Rest Of Asia Pacific: Human Organoids Market, By Culture Method, 2022–2029 (Usd Million)

Table 440 Rest Of Asia Pacific: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 441 Rest Of Asia Pacific: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 442 Rest Of Asia Pacific: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 443 Latin America: Estimated Number Of Cancer New Cases

From 2022 To 2045, Both Sexes, Age [0-85+]

Table 444 Latin America: Human Organoids Market, By Country,

2022–2029 (Usd Million)

Table 445 Latin America: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 446 Latin America: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 447 Latin America: Human Organoids Market, By Type,

2022–2029 (Usd Million)

Table 448 Latin America: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 449 Latin America: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 450 Latin America: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 451 Latin America: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 452 Brazil: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 453 Brazil: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 454 Brazil: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 455 Brazil: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 456 Brazil: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 457 Brazil: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 458 Brazil: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 459 Brazil: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 460 Mexico: Cancer Incidence, Mortality, And Prevalence, By Type, 2022

Table 461 Mexico: Human Organoids Market, By Product, 2022–2029 (Usd Million)

Table 462 Mexico: Human Organoids Market, By Source, 2022–2029 (Usd Million)

Table 463 Mexico: Human Organoids Market, By Type, 2022–2029 (Usd Million)

Table 464 Mexico: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 465 Mexico: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 466 Mexico: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 467 Mexico: Human Organoids Market, By End User, 2022–2029 (Usd Million)

Table 468 Rest Of Latin America: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 469 Rest Of Latin America: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 470 Rest Of Latin America: Human Organoids Market, By Type,

2022–2029 (Usd Million)

Table 471 Rest Of Latin America: Human Organoids Market, By Culture Method, 2022–2029 (Usd Million)

Table 472 Rest Of Latin America: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 473 Rest Of Latin America: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 474 Rest Of Latin America: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 475 Africa: Estimated Number Of New Cancer Cases

Between 0 To 85+ Of Age, 2022–2045

Table 476 Middle East & Africa: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 477 Middle East & Africa: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 478 Middle East & Africa: Human Organoids Market, By Type,

2022–2029 (Usd Million)

Table 479 Middle East & Africa: Human Organoids Market, By Culture Method, 2022–2029 (Usd Million)

Table 480 Middle East & Africa: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 481 Middle East & Africa: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 482 Middle East & Africa: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 483 Gcc Countries: Human Organoids Market, By Product,

2022–2029 (Usd Million)

Table 484 Gcc Countries: Human Organoids Market, By Source,

2022–2029 (Usd Million)

Table 485 Gcc Countries: Human Organoids Market, By Type,

2022–2029 (Usd Million)

Table 486 Gcc Countries: Human Organoids Market, By Culture Method,

2022–2029 (Usd Million)

Table 487 Gcc Countries: Human Organoids Market, By Disease Area,

2022–2029 (Usd Million)

Table 488 Gcc Countries: Human Organoids Market, By Application,

2022–2029 (Usd Million)

Table 489 Gcc Countries: Human Organoids Market, By End User,

2022–2029 (Usd Million)

Table 490 Overview Of Strategies Deployed By Key Players In

Human Organoids Market

Table 491 Human Organoids Market: Degree Of Competition

Table 492 Human Organoids Market: Region Footprint

Table 493 Human Organoids Market: Product Footprint

Table 494 Human Organoids Market: Source Footprint

Table 495 Human Organoids Market: Application Footprint

Table 496 Human Organoids Market: Detailed List Of Key Startup/Sme Players

Table 497 Human Organoids Market: Competitive Benchmarking Of

Startup/Sme Players

Table 498 Human Organoids Market: Product Launches,

January 2021– August 2024

Table 499 Human Organoids Market: Deals, January 2021–august 2024

Table 500 Thermo Fisher Scientific: Company Overview

Table 501 Thermo Fisher Scientific: Products Offered

Table 502 Thermo Fisher Scientific: Product Launches,

January 2021–august 2024

Table 503 Thermo Fisher Scientific: Deals, January 2021–august 2024

Table 504 Corning Incorporated: Company Overview

Table 505 Corning Incorporated: Products Offered

Table 506 Corning Incorporated: Deals, January 2021–august 2024

Table 507 Merck: Company Overview

Table 508 Merck: Products Offered

Table 509 Merck: Deals, January 2021–august 2024

Table 510 Merck: Expansions, January 2021–august 2024

Table 511 Bioivt: Company Overview

Table 512 Bioivt: Products Offered

Table 513 Bioivt: Deals, January 2021–august 2024

Table 514 Hub Organoids: Company Overview

Table 515 Hub Organoids: Products Offered

Table 516 Hub Organoids: Deals, January 2021–august 2024

Table 517 Bico: Company Overview

Table 518 Bico: Products Offered

Table 519 Bico: Product Launches, January 2021–august 2024

Table 520 Bico: Deals, January 2021–june 2024

Table 521 Bico: Other Developments, January 2021–august 2024

Table 522 Becytes Biotechnologies: Company Overview

Table 523 Becytes Biotechnologies: Products Offered

Table 524 Insphero: Company Overview

Table 525 Insphero: Products Offered

Table 526 Insphero: Deals, January 2021–august 2024

Table 527 Gba Group: Company Overview

Table 528 Gba Group: Products Offered

Table 529 Gba Group: Deals, January 2021–august 2024

Table 530 Kirkstall: Company Overview

Table 531 Kirkstall: Products Offered

Table 532 Mimetas: Company Overview

Table 533 Mimetas: Products Offered

Table 534 Mimetas: Product Launches, January 2021–august 2024

Table 535 Mimetas: Deals, January 2021–august 2024

Table 536 Neuromics: Company Overview

Table 537 Neuromics: Products Offered

Table 538 Primacyt Cell Culture Technology Gmbh: Company Overview

Table 539 Primacyt Cell Culture Technology Gmbh: Products Offered

Table 540 Stemcell Technologies: Company Overview

Table 541 Stemcell Technologies: Products Offered

Table 542 Stemcell Technologies: Deals, January 2021–august 2024

Table 543 Stemcell Technologies: Expansions, January 2021–august 2024

Figures List

Figure 1 Human Organoids Market: Research Design Methodology

Figure 2 Breakdown Of Primary Interviews:

Supply Side And Demand Side Participants

Figure 3 Breakdown Of Primary Interviews:

By Company Type, Designation, And Region

Figure 4 Bottom-up Approach: Company Revenue Estimation Approach

Figure 5 Cagr Projections: Supply Side Analysis

Figure 6 Human Organoids Market: Top-down Approach

Figure 7 Data Triangulation Methodology

Figure 8 Human Organoids Market, By Product, 2024 Vs. 2029 (Usd Million)

Figure 9 Human Organoids Market, By Source, 2024 Vs. 2029 (Usd Million)

Figure 10 Human Organoids Market, By Type, 2024 Vs. 2029 (Usd Million)

Figure 11 Human Organoids Market, By Culture Method,

2024 Vs. 2029 (Usd Million)

Figure 12 Human Organoids Market, By Disease Area, 2024 Vs. 2029 (Usd Million)

Figure 13 Human Organoids Market, By Application, 2024 Vs. 2029 (Usd Million)

Figure 14 Human Organoids Market, By End User, 2024 Vs. 2029 (Usd Million)

Figure 15 Human Organoids Market, By Region, 2024 Vs. 2029 (Usd Million)

Figure 16 Growing Focus On Developing Alternatives For

Animal Testing Models To Drive Market Growth

Figure 17 Liver Models To Dominate Market Till 2029

Figure 18 Adult Stem Cells Segment To Hold Largest Share Till 2029

Figure 19 Ready-to-use Products Segment To Retain Market Leadership

Figure 20 Developmental Biology And Drug Toxicity & Efficacy Testing To Command Largest Shares

Figure 21 Pharmaceutical & Biotechnology Companies Segment To

Dominate Market In 2029

Figure 22 Asia Pacific To Register Highest Growth Rate During Forecast Period

Figure 23 Human Organoids Market: Drivers, Restraints, Opportunities,

And Challenges

Figure 24 Number Of Clinical Trials, By Country, 2022

Figure 25 Number Of Articles Related To Human Organoids, 2018–2023

Figure 26 Us: Number Of Organ Transplants (2024)

Figure 27 Average Selling Price Of Fresh Cells (2024)

Figure 28 Patent Analysis For Human Organoids (January 2014–december 2023)

Figure 29 Value Chain Analysis: Major Value Added During Manufacturing

And Assembly Phases

Figure 30 Human Organoids Market: Supply Chain Analysis

Figure 31 Human Organoids Market: Ecosystem Analysis

Figure 32 Human Organoids Market: Porter’s Five Forces Analysis

Figure 33 Influence Of Stakeholders On Buying Process Of Human Organoids

Figure 34 Key Buying Criteria For Human Organoids

Figure 35 Human Organoids Market: Trends And Disruptions Impacting Customer’s Business

Figure 36 Human Organoids Market: Deals And Funding

Figure 37 Market Potential Of Ai To Enhance Research And Development In Human Organoids Market

Figure 38 North America: Human Organoids Market Snapshot

Figure 39 Asia Pacific: Human Organoids Market Snapshot

Figure 40 Revenue Analysis Of Key Players In Human Organoids Market

(2021–2023)

Figure 41 Market Share Analysis Of Key Players In Human Organoids Market (2023)

Figure 42 Human Organoids Market: Company Evaluation Matrix

(Key Players), 2023

Figure 43 Human Organoids Market: Company Footprint

Figure 44 Human Organoids Market: Company Evaluation Matrix

(Startups/Smes), 2023

Figure 45 Ev/Ebitda Of Key Vendors

Figure 46 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta

Of Key Vendors

Figure 47 Human Organoids Market: Brand Comparison For Hepatocytes

Figure 48 Thermo Fisher Scientific: Company Snapshot

Figure 49 Corning Incorporated: Company Snapshot

Figure 50 Merck: Company Snapshot

Figure 51 Bico: Company Snapshot